Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection

Promising new viral hepatitis data show that entry inhibitors a new mechanism of action for drugs to treat viral hepatitis could provide the first new hepatitis B and hepatitis D treatments for many years.